GLPGF Message Board Post 9662120 | Galapagos Genomics Ord
home / stock / glpgf / glpgf message board
M1chaeldb
(investorshub)
Posted on: Apr/03/2008 14:52:16
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=28166742
Galapagos announces 2007 full year results
News, Short Squeeze, Breakout and More Instantly...
-
Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual Euro...
-
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’ decentralized manufacturing platform in patients with head & neck cancer Uza-cel has shown enc...
-
BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centers Collaboration enables rapid deployment of Galapagos' decentralized CAR-T platform across the U.S., improving patient access ...